ALEC’s Health and Human Services Task Force Director: “Don’t Import Prescription Drugs”

In this editorial published in The Hill on May 12, 2019, Brooklyn Roberts, the director of the health and human services task force at the American Legislative Exchange Council, discusses the risks of drug importation:

“The safety of our prescription drugs relies on a closed system where drugs can be traced to manufacturers, distributors, pharmacies and patients. Opening that system to foreign drugs would allow the potential for dangerous and potentially deadly medicines to land in the hands of the American public.”

[...]

Former FDA Commissioner Scott Gottlieb condemns importation proposals and points out Florida’s sordid history with wholesale counterfeit drugs

Today at the National Press Club former FDA Commissioner Scott Gottlieb addressed the issue of importation and specifically talked about the irony of Florida attempting to do it. Commissioner Gottlieb reminded us that the reason we have the pedigree system we’re implementing now (Track and Trace) is because criminal wholesalers in Florida in the early…

[...]

Former FBI Director Warns About the Hidden Risks of Drug Importation

In this editorial published on April 30, 2019, former FBI Director Louis Freeh talks about the safety risks of drug importation: “There are hidden risks and costs associated with the scheme that have not been getting much attention which impact your health and Colorado law enforcement’s ability to keep us safe.”

[...]

Economist questions the fundamentals of importation: “It flunks a basic policy analysis.”

In this editorial published on April 26, 2019, Douglas Holtz-Eakin, economist and President of American Action Forum, questions economic truths about drug importation:

“Drug reimportation has long been the fool’s gold of health policy, and the Florida bill is no different. It flunks a basic policy analysis. But most amazing, it is drafted to raise hope, but not actually help Floridians.”

[...]

Journalist on drug importation: “There is a real risk.”

In this piece published in the Washington Free Beacon on April 25, 2019, staff writer Charles Fain Lehman explores issues around Florida’s drug importation proposal. “Critics,” he notes, “fear that the actual realities of regulatory oversight—especially in the hand of an as-yet-unnamed private vendor—will simply be too challenging to manage responsibly.”

[...]

Utah pharmacist and state senator: Importation raises “serious concerns about drug safety”

In this piece, which was published in The Deseret News on April 24, 2019, pharmacist and Utah State Senate Majority Leader Evan Vickers raises serious concerns about importation as a strategy to lower drug prices:

“Anyone who truly understands how drugs are sold and distributed in the U.S. knows that there are very solid technical reasons that such importation is not viable. There are also serious concerns about drug safety, since the CHS cannot guarantee origin and purity on foreign-sourced drugs.”

[...]